Oct 1, 2026 05:03AM
Sep 18, 2026 04:11AM
Aug 17, 2026 06:26AM
Aug 12, 2026 04:15PM
Jun 3, 2026 04:08PM
May 14, 2026 04:09PM
Apr 30, 2026 04:15PM Cue Biopharma licenses anti-IgE antibody in $691.5 million deal
Mar 17, 2026 11:33AM
Feb 12, 2026 08:02AM
Nov 20, 2025 04:04PM
Nov 18, 2025 04:30AM
Nov 13, 2025 01:11PM
Nov 13, 2025 06:27AM
Sep 29, 2025 09:00AM Cue Biopharma names Usman Azam as new CEO effective September 29
Aug 25, 2025 06:35AM
Aug 12, 2025 05:47PM
Jul 1, 2025 04:05PM
Jun 24, 2025 04:48PM
May 30, 2025 05:01AM
May 13, 2025 07:02AM
Apr 21, 2025 04:23AM Citizens JMP Reiterates Market Outperform Rating on Cue Biopharma (CUE)
Apr 15, 2025 04:09AM
Apr 14, 2025 05:06PM
Apr 14, 2025 05:00PM
Apr 2, 2025 04:38AM
Nov 15, 2024 08:59AM
Nov 15, 2024 07:07AM
Nov 8, 2024 01:31PM Cue Biopharma (CUE) Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102
Sep 27, 2024 06:04AM
Sep 26, 2024 04:27PM
Sep 9, 2024 08:03AM
Aug 20, 2024 07:32AM
Aug 20, 2024 05:16AM
Aug 19, 2024 04:20PM
Jul 26, 2024 07:44AM Cue Biopharma (CUE) PT Lowered to $3 at Piper Sandler
Jul 25, 2024 04:05PM

479,047 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All